pqq cofactor has been researched along with Pulmonary Hypertension in 1 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shafiq, M | 1 |
| Lone, ZR | 1 |
| Bharati, P | 1 |
| Mahapatra, S | 1 |
| Rai, P | 1 |
| Khandelwal, N | 1 |
| Gaikwad, AN | 1 |
| Jagavelu, K | 1 |
| Hanif, K | 1 |
1 other study available for pqq cofactor and Pulmonary Hypertension
| Article | Year |
|---|---|
Pyrroloquinoline quinone (PQQ) improves pulmonary hypertension by regulating mitochondrial and metabolic functions.
Topics: Animals; Endothelial Cells; Humans; Hypertension, Pulmonary; Inflammation; Monocrotaline; PQQ Cofact | 2022 |